Insider · CIK 0002108597
Martin William Dewhurst
Files at TTRX (Turn Therapeutics Inc.). First filing -, latest -.
Martin William Dewhurst files SEC Form 4 as director at TTRX (Turn Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Martin William Dewhurst has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | TTRX Turn Therapeutics Inc. | AGrant or award Stock option (right to buy)derivative | +71,666 | $0.00 | $0 | 71,666 | Jun 8, 2026 |
| Jan 7, 2026 | TTRX Turn Therapeutics Inc. | AGrant or award Common Stock | +21,882 | $0.00 | $0 | 21,882 | Feb 4, 2026 |
Questions about Martin William Dewhurst
Answered from the filings on this page, as of the latest one.
Is Martin William Dewhurst buying or selling?
Martin William Dewhurst has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Martin William Dewhurst's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martin William Dewhurst has 0.
Where does Martin William Dewhurst file Form 4?
Martin William Dewhurst has filed Form 4 at TTRX (Turn Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.